A case-control study nested within a large cohort, the American Cancer Society Cancer Prevention Study-1, was conducted to test associations between a family history of cancer and cancer mortality in women. By using logistic regression, the authors analyzed family history, as reported by 429,483 women enrolled in 1959, relative to subsequent mortality through 1972 from cancer within and across multiple sites. The associations between family history and cancer mortality were generally stronger within cancer sites than across cancer sites. Withinsite associations were found for breast cancer (odds ratio (OR) = 1.9), colorectal cancer (OR = 1.6), stomach cancer (OR = 1.9), and lung cancer (OR = 1.7). Across-site associations were observed for a family history of 1) breast cancer as a risk factor for ovarian cancer mortality (OR = 1.6), 2) stomach cancer as a risk factor for ovarian cancer mortality (OR = 1.5), and 3) uterine cancer as a risk factor for pancreatic cancer mortality (OR = 1.6). A general pattern of positive associations was observed between a family history of cancer at several sites and subsequent death from pancreatic cancer. These findings support the growing body of evidence from cancer genetics suggesting that inherited cancer-susceptibility genes increase the risk for cancer at many sites and are not specific to cancer risk within a single site. Am J Epidemiol 1999; 149:454-62.
The role of a family history of cancer as a cancer risk factor has been the subject of numerous studies, particularly cancer that develops at common sites, such as breast cancer (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) and colorectal cancer (2, 6, (16) (17) (18) (19) (20) (21) (22) . Most studies have been site specific, examining the role of a family history of cancer only within a particular site. However, over a dozen cancer family syndromes have now been described, most of which involve inherited risk across multiple cancer sites (23) (24) (25) (26) (27) . Few epidemiologic studies have been large enough to examine the relation between a family history of cancer and cancer risk both within and across multiple cancer sites. To our knowledge, only two previous studies (2, 6 ) have systematically examined a family history of cancer as a risk factor for cancers of multiple other sites. We examined the extent to which a family history of cancer, as reported by a large number of women, might be a risk factor for cancer mortality both within the same cancer site and across multiple cancer sites. Evidence of new patterns of associations within and across cancer sites could provide both epidemiologic and genetic researchers with additional hypotheses for analysis.
MATERIALS AND METHODS
The study subjects were women enrolled in the Cancer Prevention Study-1 (CPS-1), a prospective study begun in 1959 and continued through 1972 in which American Cancer Society volunteers enrolled over 1 million men and women. The CPS-1 thus provides a large database for a population-based study of the effect of family history on cancers within and across sites. Because of the difficulty in presenting numerous analyses in a single report, we elected to present findings for the women only.
Each subject, aged 30 years or older, completed a questionnaire that contained detailed questions about the occurrence of cancer in family members. Information on a family history of cancer, including both incident cancers and cancer mortality as well as age at diagnosis and cancer site, was collected only when the initial self-administered questionnaire was completed. In our study, family history was defined as any first-degree relative (parent or sibling) who had been diagnosed with the specified cancer reported by subjects. Although the CPS-1 includes information about the occurrence of cancer in grandparents, these data were not included in our analysis because of the generally poorer reliability of those reports (28) . The vital status of subjects (not family members) was ascertained periodically by American Cancer Society volunteers through 1972. All 1959-1972 deaths among Family History and Cancer Mortality 455 subjects were verified by using death certificates and were coded by nosologists for the underlying cause of death. Cause of death was determined for 92.2 percent of the original cohort. Additional details of the study have been published previously (29) .
There were 594,551 women in the original cohort; 10,055 (1.7 percent) were lost to follow-up, 32,665 (5.5 percent) did not complete their own baseline questionnaires, 97,197 (16.3 percent) had missing or incomplete data on family history or other covariates, and 25,151 (4.2 percent) reported a cancer other than nonmelanoma skin cancer during the baseline survey. Therefore, the analytic cohort for this study comprised the remaining 429,483 women (72.2 percent of the original cohort) who completely filled out their own questionnaires, were cancer free at baseline, and were followed up through 1972.
Among these women, 12,354 died of cancer during 1959-1972. The numbers of deaths from cancer at the leading sites and the numbers of reports of a family history of cancer at those sites are presented in appendix table 1. All sites for which 500 or more cohort members reported a family history and all sites with 100 or more cancer deaths among subjects were selected for analysis. There were two exceptions to this general approach: general groupings such as "other and unspecified" and a family history of liver cancer were not included in the analyses. Although almost 10,000 subjects reported a family history of liver cancer, these reports were regarded as fairly unreliable (28) , as the liver is often a metastatic site. We selected for logistic regression analysis (30) those associations with 10 or more cancer deaths expected under the null hypothesis among those women with a positive family history, which produced 70 comparisons. For seven sites, we subclassified family history as "higher familial risk" when two or more family members were reported to have been diagnosed with cancer at the same site or when any family member had the specified cancer prior to age 50 years. The sites selected for that subanalysis were those for which associations between family history and cancer risk had been reported previously and those for which the CPS-1 data showed consistent associations between family history and cancer risk (colorectal, breast, stomach, lung, uterus, prostate, and pancreas). For these same sites, we also subclassified family history of cancer as only among parents or only among siblings.
The association between a family history of cancer and subsequent cancer mortality was assessed by using case-control analyses. We developed two logistic regression models, a basic model to adjust for age and race and a full model to control for potential confounders for smoking-related and hormone-related cancers. In addition to age (in years) at interview and race (white/other), the full model also included dummy variables for education (1-8 years, some high school, high school graduate, some college, college graduate), smoking status (never smoker, ex-smoker, current smoker), body mass index (in kg/m 2 ), age (in years) that menses began (<11, 12-14, >15), number of pregnancies (none, 1-2, 3-A, >5), number of brothers, number of sisters, and age (in years) at first pregnancy (none, 10-19, 20-24, 25-29, >30 ). To evaluate potential differences between this method and a person-time analysis, we performed Cox proportional hazard analysis (31); no differences were found in the results obtained by using these different analytical models.
RESULTS
The distribution of the variables included in the full model for those with and without a positive family history of cancer are shown in table 1. We observed little difference in these variables between the two groups. Because these risk factors were only weakly associated with family history and varied little between cases and controls, they were not confounders in the regression models. Findings were nearly identical for the basic and full models, so only the multivariate odds ratios and their related 95 percent confidence intervals for the full model have been included in table 2.
Overall, we observed stronger associations within cancer sites than across cancer sites for breast, colorectal, stomach, and lung cancers (table 2). Significant across-site associations were found for ovarian cancer mortality among those with a family history of breast cancer and among those with a family history of stomach cancer. Breast and pancreatic cancers exhibited a pattern of reciprocal association, in which there was a similar increased risk of mortality for each type of cancer with a family history of the other type. Death from pancreatic cancer tended to be associated with a family history of cancer across several sites.
Analyses of selected sites showed that a generally higher risk was associated with a strong family history as defined by multiple affected first-degree relatives or any first-degree relative diagnosed before age 50 years (table 3) . However, the differences in risk between those in the minimal and those in the higher familial risk groups were not great. Likewise, no clear pattern of differing risk emerged between those women with affected siblings and those with affected parents (table 3) . 24 13 * Total exceeds the number of cohort members because the categories are not mutually exclusive. t No family history of breast, lung, colorectal, stomach, liver, skin, uterus, oral, prostate, bladder, cervical, bone, kidney, brain, or pancreatic cancer; leukemia; or Hodgkin's disease.
$ Includes colorectal, stomach, liver, skin, uterus, oral, prostate, bladder, cervical, bone, kidney, brain, and pancreatic cancer; leukemia; and Hodgkin's disease.
reported in prior studies (table 4). Our observation that within-site associations were generally stronger than across-site associations is consistent with the findings of most (1, 2, 4, 6, 10, 21, 32-34) but not all (9, 17) other studies that have made these comparisons. The reason for this site specificity is unknown but could be due to either different expressions of genes in different tissues or environmental factors shared by family members.
The meaning of differences in cancer risk imparted by sibling cancer history versus parental cancer history is unclear. It may be that in some studies, some of the higher risk associated with a history of affected siblings is due to the generally younger ages at which cancer is diagnosed in siblings than in parents at a single point in time. Therefore, a history of affected siblings may be a marker of heritable disease often accompanied by an early age of onset. Both our findings and those published previously by others were mixed. For a family history of breast cancer, our finding of similar risks for women with affected mothers * Adjusted for age at interview, number of brothers, number of sisters, race, education, smoking status (current, ex, never), body mass index, age that menses began, number of pregnancies, and age at first pregnancy.
t Only one family member with cancer at this site and no family member with cancer before age 50 years. t Two or more family members with cancer at this site or one family member with cancer at this site before age 50 years. § Family history of cancer at this site in the parents only. 1) Family history of cancer at this site in the siblings only.
and women with affected sisters is not consistent with five previous studies that showed a higher risk for those with affected sisters (3, 4, 7, 9, 11), although one previous study found a higher risk for women with affected mothers (12) . For colorectal cancer mortality, our finding of a higher risk for those women with affected siblings versus those with affected parents contrasts with the findings of St. John et al. (19) but supports those of La Vecchia et al. (22) . We found a higher risk for women who reported a sibling history of lung cancer, whereas Wu et al. (32) found no difference in risk between parental and sibling history. The presence of multiple family members who are affected with the same cancer or family members who are affected at an early age is often considered an indication of inherited cancer risk. Conversely, a few recent studies have suggested that the absence of these indicators does not preclude the presence of heritable disease. For breast cancer, for instance, Couch et al. (35) found that the number of breast cancers in a family was not a good independent predictor of the presence of a BRCA1 gene mutation, and Barker et al. (36) reported that persons with the BRCA1 R841W alteration did not tend to be diagnosed with breast cancer at an early age. Two studies (3, 7) found an increased risk for breast cancer when the family member was affected at an earlier age, which is similar to our finding of an increased risk in the higher risk group. However, one study (8) found no difference. La Vecchia et al. (22) also found an increased risk for colorectal cancer mortality when two or more relatives were affected, which is consistent with our study.
In most across-site analyses, we found smaller risks than those reported in previous studies (table 4). One exception was for lung cancer mortality; we found a slightly higher association than did Wu et al. (32) for a family history of breast cancer. To our knowledge, our observation of an increased risk for breast cancer mortality among those reporting a family history of brain cancer has not been reported in other studies, and an increased risk for breast cancer mortality among those reporting a family history of pancreatic cancer has been reported only once (2) . Interestingly, brain, pancreatic, and breast cancers are included in the LiFraumeni cancer syndrome (37) . Although this syndrome is too rare in the general population to explain these findings fully, it suggests that there may be other similar genetic mechanisms that can affect cancer risks across these same cancer sites or common inherited variations in cancer-relevant genes.
We found an increased risk for death from pancreatic cancer with reports of five different family histories of cancer: colorectal, breast, stomach, lung, and uterus. We know of no previous epidemiologic reports whose findings are similar to ours. Although only the association with a family history of uterine cancer was Am J Epidemiol Vol. 149, No. 5, 1999 statistically significant, the general pattern of these positive associations between a family history of cancer and pancreatic cancer mortality may be noteworthy for several reasons. Pancreatic cancer has been associated with a number of cancer family syndromes-Li-Fraumeni cancer syndrome (37), PeutzJeghers syndrome (38) , mutation of the BRCA2 gene (39^42), hereditary nonpolyposis colorectal cancer (43) , and multiple endocrine neoplasia syndrome type I (44) . The observation that the risk for pancreatic cancer mortality was consistently higher among those with a higher familial risk (table 3) and that pancreatic cancer and breast cancer exhibited similar reciprocal associations (table 2) provides additional evidence for an inherited risk. Phelan et al. (42) found the presence of a family history of pancreatic cancer to be a significant predictor of the presence of BRCA2 gene mutation.
Previously reported associations that we expected to observe but did not include an increased risk for colorectal cancer based on a family history of breast cancer (6, 17, 21) and an increased risk for breast cancer among those with a family history of prostate cancer (1, 2, 4, 6, 9) (table 4). Ascertainment of cancers and cancer sites for family members in the CPS-1 is limited to the accuracy of recall of those interviewed and was not verified independently. Love et al. (28) found that almost 97 percent of subjects correctly reported the occurrence of cancer in a first-degree family member but that the accuracy of identification of the primary cancer site reported in first-degree relatives varied considerably by cancer site. In particular, reports regarding the lung and liver were less than 60 percent and 5 percent accurate, respectively. The accuracy of reported family history is likely to vary in our study as well. The pattern of risk for pancreatic cancer may in part be due to associations between pancreatic cancer mortality and a family history of pancreatic cancer that have been reported incorrectly as involving other abdominal cancers, although Love et al. found that a family history of pancreatic cancer as a primary site was reported correctly 71 percent of the time.
Many reports of an increased risk of cancer for those with family histories of cancer at other sites can be found in the genetics research literature. For example, several studies have reported various cancer sites that are linked to BRCA2 mutations (39) (40) (41) (42) . Likewise, the association between breast, ovarian, and other cancers within families suggests that general cancer risks are associated with BRCA1 mutations. Given what is known about the role of genes such as the BRCA1 in the regulation of cellular functions, there is little reason to think, a priori, that inherited mutations lead to an increased risk of cancer at only specific organ sites. This conclusion points to the need to identify other environmental and genetic factors that might determine the specific organ site at which cancers emerge among people with cancer-relevant genetic mutations. One such study by Marquis et al. (45) examined how changes in hormone levels during different developmental stages might lead to the expression of BRCA1-induced neoplasms in the breast even though BRCA1 mutations are distributed in many tissues that are susceptible to neoplasia.
Although we conducted numerous analyses, the pattern of findings is unlikely to be due to chance alone. About 10 percent of the associations we tested were statistically significant, and all indicated an increased risk for cancer mortality among those women with a positive family history. These analyses are limited because mortality rather than incidence was the endpoint. Therefore, our results could have been influenced by factors that affect cancer survival as well as cancer incidence. Nevertheless, our results for withinsite associations of breast, colorectal, and lung cancers are similar to findings from other studies of incident cancers (1-4, 6-14, 17-22, 32, 46) . Since many of these cancers have high fatality rates (e.g., lung, stomach, pancreas, ovary), limiting the analysis to cancer deaths likely would have had little effect on the associations of a family history of cancer at these sites. Although we were able to control for a number of other risk factors in subjects, we cannot rule out the effect of environmental factors shared by families, particularly for those cancers, such as colorectal (16) , stomach, and pancreas (47) , in which diet has been associated with an increased risk.
In this study, we were able to control for the major confounders associated with smoking-related and hormone-related cancers. Even after adjusting for these factors, we observed several across-site associations that may indicate a general genetic susceptibility to cancer. Of particular note was the pattern of increased risk for pancreatic cancer mortality associated with a reported family history of several other cancers. While site specificity has clear clinical relevance, both geneticists and epidemiologists should tailor their study strategies to assess genetic and gene-environment factors that affect cancer risk across a range of cancer types to identify more general mechanisms underlying cancer risk.
